APOH and autoimmune polyendocrinopathy: Vega-Ostertag and colleagues demonstrated that TIFI blocked binding of β2GPI to human umbilical vein endothelial cells in-vitro and also inhibited thrombosis caused by passive administration of IgG from patients with APS in the same model that we previously used (27).